Related Experiment Video
Updated: Aug 30, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Lymphomas and oncolytic virus therapy
Tommy Alain1, Chandini Thirukkumaran, Donald G Morris
1Cancer Biology Research Group, University of Calgary, Alberta, Canada. talain@ucalgary.ca
Abstract:
There are several well-documented cases in medical literature of the remission of leukemias and malignant lymphomas following natural human viral infections. In the hope of being able to reproduce these spontaneous tumor regressions, investigators have studied various viruses with distinct oncolytic properties. The first attempts to treat patients with oncolytic viruses took place > 80 years ago; however, it achieved little success. With modern technologies and current knowledge of viruses and cancer, there is an expectation for the discovery of efficient oncolytic viral therapies. This article will review the current knowledge of oncolytic viruses in relation to the treatment of lymphoma.
Insights
Oncolytic viruses, capable of targeting and destroying cancer cells, offer a promising avenue for treating leukemias and lymphomas. Modern research aims to harness these viruses for effective cancer therapies.
Area of Science:
- Oncology
- Virology
- Immunology
Background:
- Spontaneous remission of leukemias and lymphomas has been observed following natural viral infections.
- Early attempts at viral oncolysis yielded limited success due to technological constraints.
Purpose of the Study:
- To review current knowledge on oncolytic viruses for lymphoma treatment.
- To explore the potential of oncolytic virotherapy in cancer remission.
Main Methods:
- Review of medical literature on viral infections and cancer remission.
- Analysis of historical and modern research on oncolytic viruses.
- Focus on viruses with demonstrated oncolytic properties.
Main Results:
- Documented cases of leukemia and lymphoma remission linked to viral infections.
- Identification of viruses with distinct oncolytic capabilities.
- Advancements in technology and understanding of cancer biology.
Conclusions:
- Oncolytic virotherapy holds significant promise for future cancer treatment strategies.
- Modern approaches are expected to yield more efficient oncolytic viral therapies.
- Further research is warranted to optimize oncolytic virus applications in lymphoma treatment.
Related Concept Videos
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
